These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30333606)

  • 21. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers.
    Mandl CW
    Viral Immunol; 2004; 17(4):461-72. PubMed ID: 15671744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells.
    Hassert M; Brien JD; Pinto AK
    Front Immunol; 2019; 10():1045. PubMed ID: 31143185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
    Whitehead SS; Durbin AP; Pierce KK; Elwood D; McElvany BD; Fraser EA; Carmolli MP; Tibery CM; Hynes NA; Jo M; Lovchik JM; Larsson CJ; Doty EA; Dickson DM; Luke CJ; Subbarao K; Diehl SA; Kirkpatrick BD
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005584. PubMed ID: 28481883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are tree squirrels involved in the circulation of flaviviruses in Italy?
    Romeo C; Lecollinet S; Caballero J; Isla J; Luzzago C; Ferrari N; García-Bocanegra I
    Transbound Emerg Dis; 2018 Oct; 65(5):1372-1376. PubMed ID: 29635877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
    McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ
    PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response.
    King NJ; Kesson AM
    Immunol Cell Biol; 2003 Jun; 81(3):207-16. PubMed ID: 12752685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the complement system in antibody-dependent enhancement of flavivirus infections.
    Byrne AB; Talarico LB
    Int J Infect Dis; 2021 Feb; 103():404-411. PubMed ID: 33352325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavivirus RNAi suppression: decoding non-coding RNA.
    Pijlman GP
    Curr Opin Virol; 2014 Aug; 7():55-60. PubMed ID: 24793201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Duck Flavivirus Is Not Pathogenic for Primates and Is Highly Sensitive to Mammalian Interferon Antiviral Signaling.
    Wang HJ; Li XF; Liu L; Xu YP; Ye Q; Deng YQ; Huang XY; Zhao H; Qin ED; Shi PY; Gao GF; Qin CF
    J Virol; 2016 Jul; 90(14):6538-6548. PubMed ID: 27147750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIAID workshop on Flavivirus immunity.
    Augustine AD; Cassetti MC; Ennis FA; Harris E; Hildebrand WH; Repik PM
    Viral Immunol; 2010 Jun; 23(3):235-40. PubMed ID: 20565288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
    VanBlargan LA; Goo L; Pierson TC
    Microbiol Mol Biol Rev; 2016 Dec; 80(4):989-1010. PubMed ID: 27784796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.
    Mehlhop E; Ansarah-Sobrinho C; Johnson S; Engle M; Fremont DH; Pierson TC; Diamond MS
    Cell Host Microbe; 2007 Dec; 2(6):417-26. PubMed ID: 18078693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Flaviviral Proteins in the Induction of Innate Immunity.
    Cedillo-Barrón L; García-Cordero J; Shrivastava G; Carrillo-Halfon S; León-Juárez M; Bustos Arriaga J; León Valenzuela P; Gutiérrez Castañeda B
    Subcell Biochem; 2018; 88():407-442. PubMed ID: 29900506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses.
    Diamond MS
    J Interferon Cytokine Res; 2009 Sep; 29(9):521-30. PubMed ID: 19694536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.
    Holbrook MR; Shope RE; Barrett AD
    J Clin Microbiol; 2004 Sep; 42(9):4101-10. PubMed ID: 15364996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mimicking live flavivirus immunization with a noninfectious RNA vaccine.
    Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flaviviruses and their antigenic structure.
    Heinz FX; Stiasny K
    J Clin Virol; 2012 Dec; 55(4):289-95. PubMed ID: 22999801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.